From: Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions
 |  |  | LCISb | Associated lesion |  |  | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |  |  | IHC profile | E-cadherin | Histology | Gradec | IHC profile | E-cadherin |  |  | ||||
Pair | Casea | Mastectomy | ER | PR | HER2 | Â | Â | Â | ER | PR | HER2 | Â | P value | Diagnosisd |
LCIS and ILC | #32 | Bilateral | + | + | - | NA | ILC classic | I | + | + | - | NA | 0.07 | I |
 | #43 | Left | + | + | - | NA | ILC classic | I | + | + | - | NA | 0.99 | I |
 | #93 | Left | + | + | - | - | ILC solid variant | II | + | + | - | - | 0.004 | E |
 | #107 | Bilateral | + | + | - | - | ILC classic | I | + | + | - | - | 0.013 | E |
 | #114a | Bilateral | + | + | - | NA | ILC classic | I | + | + | - | NA | < 0.001 | C |
 | #114b | Bilateral | + | + | - | NA | ILC classic | I | + | + | - | NA | < 0.001 | C |
 | #121 | Left | + | + | - | NA | ILC variant | II | + | + | - | NA | 0.30 | I |
 | #122 | Bilateral | + | + | - | - | ILC pleomorphic | III | + | + | - | - | < 0.001 | C |
 | #126 | Right | + | + | - | NA | ILC classic | I | + | + | - | NA | 0.009 | E |
LCIS and DCIS | #84 | Bilateral | + | + | - | - | DCIS cribiform | Group 1 | + | + | - | + | < 0.001 | C |
 | #95 | Left | + | + | - | NA | DCIS micropapillary | Group 3 | + | + | - | NA | < 0.001 | C |
 | #110 | Bilateral | + | + | - | - | DCIS cribiform | Group 1 | + | + | - | + | 0.031 | E |
 | #120 | Bilateral | + | + | - | - | DCIS papillary | Group 3 | - | - | - | + | 0.96 | I |
LCIS and IDC-LF | #76 | Bilateral | + | + | - | - | ILC and IDC NST | II | + | + | - | ILC-negative, IDC-positive | < 0.001 | C |
 | #83 | Left | + | + | - | - | ILC and IDC NST | I | + | + | - | - | 0.12 | I |
LCIS and IDC | #95 | Left | + | + | - | NA | IDC NST | III | + | + | - | NA | < 0.001 | C |
 | #110 | Bilateral | + | + | - | - | IDC NST and micropapillary | II | + | + | - | + | 0.004 | E |